APYX MEDICAL CORP (APYX) Forecast, Price Target & Analyst Ratings

Name: APYX MEDICAL CORP (APYX) Analyst Consensus Rating
Brand: APYX MEDICAL CORP
Rating: 8 (11 reviews)

NASDAQ:APYX • US03837C1062

3.64 USD

-0.2 (-5.21%)

At close: Mar 27, 2026

3.64 USD

0 (0%)

After Hours: 3/27/2026, 8:00:58 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APYX MEDICAL CORP (APYX).

Consensus Price Target

Price Target

$5.87

+ 61.13% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: May 6, 2026
Period: Q1 / 2026
EPS Estimate: -$0.11
Revenue Estimate: 11.126M

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

80.00%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$5.87

Upside

+ 61.13%

From current price of $3.64 to mean target of $5.87, Based on 11 analyst forecasts

Low

$4.04

Median

$5.61

High

$8.40

Price Target Revisions

1 Month

0.00%

3 Months

1.47%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for APYX. The average price target is 5.87 USD. This implies a price increase of 61.13% is expected in the next year compared to the current price of 3.64.

The average price target has been revised upward by 1.47% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

80.00%

APYX was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about APYX.

In the previous month the buy percentage consensus was at a similar level.

APYX was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2026-03-11	BTIG	Upgrade	Neutral -> Buy
2026-03-11	Craig-Hallum	Maintains	Buy -> Buy
2025-12-16	Roth Capital	Initiate	Buy
2025-11-12	Citizens	Upgrade	Market Perform -> Market Outperform
2024-10-17	BTIG	Initiate	Neutral
2024-09-16	JMP Securities	Reiterate	Market Perform
2023-11-10	Stephens & Co.	Maintains	Overweight -> Overweight
2023-08-11	Piper Sandler	Maintains	Overweight -> Overweight
2023-07-14	Stephens & Co.	Initiate	Overweight
2023-06-15	Lake Street	Maintains	Buy
2023-05-24	JMP Securities	Reiterate	Market Perform -> Market Perform
2023-05-12	Lake Street	Maintains	Buy -> Buy
2022-08-12	Piper Sandler	Maintains	Overweight
2022-07-19	Lake Street	Maintains	Buy
2022-05-20	Lake Street	Initiate	Buy
2021-08-13	JMP Securities	Maintains	Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date: May 6, 2026
Period: Q1 / 2026
EPS Estimate: -$0.11
Revenue Estimate: 11.126M
Revenue Q2Q: 17.99%
EPS Q2Q: -8.12%
Number of Analysts: 7

Next Earnings Revisions

Revenue (1 Month)

6.49%

Revenue (3 Months)

5.65%

EPS (1 Month)

7.83%

EPS (3 Months)

6.47%

Next Earnings Summary

APYX is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.11 USD and the consensus revenue estimate is 11.13M USD.

The next earnings revenue estimate has been revised upward by 5.65% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2023	2024	2025	2026	2027	2028	2029	2030
Revenue YoY % growth	52.349M 17.61%	48.102M -8.11%	52.844M 9.86%	59.144M 11.92%	65.106M 10.08%	74.072M 13.77%	272.59M 268.01%	361.19M 32.50%
EBITDA YoY % growth	-19.259M 15.05%	-18.246M 5.26%	-5.791M 68.26%	-7.669M -32.42%	-5.147M 32.88%	14.178M 375.44%	N/A	N/A
EBIT YoY % growth	-19.951M 15.32%	-18.845M 5.54%	-6.446M 65.79%	-9.059M -40.54%	-6.995M 22.78%	3.704M 152.95%	40.889M 1,003.91%	72.237M 76.67%
Operating Margin	-38.11%	-39.18%	-12.20%	-15.32%	-10.74%	5.00%	15.00%	20.00%
EPS YoY % growth	-0.62 7.46%	-0.67 -8.06%	-0.27 59.70%	-0.37 -37.89%	-0.34 9.59%	-0.03 90.91%	N/A	N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q1 / 26	Q2 / 26	Q3 / 26	Q4 / 26	Q1 / 27	Q2 / 27	Q3 / 27	Q4 / 27
EPS Q2Q % growth	-0.11 -8.12%	-0.10 -10.50%	-0.09 -83.60%	-0.06 -113.35%	-0.10 3.77%	-0.09 5.64%	-0.10 -12.22%	-0.09 -35.46%
Revenue Q2Q % growth	11.126M 17.99%	12.643M 11.17%	14.005M 8.76%	18.678M -2.54%	N/A	N/A	N/A	N/A
EBITDA Q2Q % growth	-3.323M -14.07%	-2.372M -2.94%	-1.74M -337.22%	-104.04K -115.62%	N/A	N/A	N/A	N/A
EBIT Q2Q % growth	-4.05M -32.75%	-3.195M -24.14%	-2.639M -217.16%	-927.69K -8,533.55%	N/A	N/A	N/A	N/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

23.57%

EPS Next 5 Year

N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

11.71%

Revenue Next 5 Year

46.71%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

57.41%

EBIT Next 5 Year

N/A

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

APYX MEDICAL CORP / APYX Forecast FAQ

What do analysts expect the price target to be for APYX MEDICAL CORP (APYX)?

11 analysts have analysed APYX and the average price target is 5.87 USD. This implies a price increase of 61.13% is expected in the next year compared to the current price of 3.64.

What is the next earnings date for APYX stock?

APYX MEDICAL CORP (APYX) will report earnings on 2026-05-06, before the market open.

What are the consensus estimates for APYX stock next earnings?

The consensus EPS estimate for the next earnings of APYX MEDICAL CORP (APYX) is -0.11 USD and the consensus revenue estimate is 11.13M USD.

How many analysts have analysed APYX MEDICAL CORP (APYX)?

The number of analysts covering APYX MEDICAL CORP (APYX) is 11.

Analyst forecast overview

Forecast Snapshot